• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Specificity of bactericidal antibody response to serogroup B meningococcal strains in Brazilian children after immunization with an outer membrane vaccine.巴西儿童接种外膜疫苗后对B群脑膜炎球菌菌株杀菌抗体反应的特异性
Infect Immun. 1998 Oct;66(10):4755-61. doi: 10.1128/IAI.66.10.4755-4761.1998.
2
The VR2 epitope on the PorA P1.7-2,4 protein is the major target for the immune response elicited by the strain-specific group B meningococcal vaccine MeNZB.PorA P1.7-2,4蛋白上的VR2表位是菌株特异性B群脑膜炎球菌疫苗MeNZB引发免疫反应的主要靶点。
Clin Vaccine Immunol. 2006 Apr;13(4):486-91. doi: 10.1128/CVI.13.4.486-491.2006.
3
Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine.六价脑膜炎球菌外膜囊泡疫苗诱导产生的人抗PorA P1.7,16杀菌抗体的特异性
Infect Immun. 1996 Jul;64(7):2745-51. doi: 10.1128/iai.64.7.2745-2751.1996.
4
Serosubtypes and PorA types of Neisseria meningitidis serogroup B isolated in Brazil during 1997--1998: overview and implications for vaccine development.1997 - 1998年期间在巴西分离出的B群脑膜炎奈瑟菌的血清亚型和PorA类型:概述及其对疫苗研发的意义。
J Clin Microbiol. 2001 Aug;39(8):2897-903. doi: 10.1128/JCM.39.8.2897-2903.2001.
5
Human B- and T-cell responses after immunization with a hexavalent PorA meningococcal outer membrane vesicle vaccine.用六价PorA脑膜炎球菌外膜囊泡疫苗免疫后的人B细胞和T细胞反应
Infect Immun. 1997 Dec;65(12):5184-90. doi: 10.1128/iai.65.12.5184-5190.1997.
6
Cross-reactivity of antibodies against PorA after vaccination with a meningococcal B outer membrane vesicle vaccine.接种B群脑膜炎球菌外膜囊泡疫苗后针对PorA的抗体交叉反应性。
Infect Immun. 2003 Apr;71(4):1650-5. doi: 10.1128/IAI.71.4.1650-1655.2003.
7
Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine.脑膜炎球菌PorA外膜蛋白序列变异对六价PorA外膜囊泡疫苗有效性的影响。
Vaccine. 2000 May 22;18(23):2476-81. doi: 10.1016/s0264-410x(00)00047-5.
8
Antibody specificities and effect of meningococcal carriage in icelandic teenagers receiving the Norwegian serogroup B outer membrane vesicle vaccine.冰岛青少年接种挪威B群脑膜炎球菌外膜囊泡疫苗后的抗体特异性及脑膜炎球菌携带情况的影响
Infect Immun. 2003 Jul;71(7):3775-81. doi: 10.1128/IAI.71.7.3775-3781.2003.
9
Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States. The Active Bacterial Core Surveillance Team.美国流行的B群脑膜炎奈瑟菌血清亚型和血清型分布。活跃细菌核心监测团队。
J Clin Microbiol. 2000 Sep;38(9):3323-8. doi: 10.1128/JCM.38.9.3323-3328.2000.
10
Immune responses against major outer membrane antigens of Neisseria meningitidis in vaccinees and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial.在挪威B群脑膜炎球菌保护试验期间感染脑膜炎球菌病的疫苗接种者和对照者中,针对脑膜炎奈瑟菌主要外膜抗原的免疫反应。
Infect Immun. 1998 Jul;66(7):3223-31. doi: 10.1128/IAI.66.7.3223-3231.1998.

引用本文的文献

1
OpcA and PorB are novel bactericidal antigens of the 4CMenB vaccine in mice and humans.OpcA和PorB是4CMenB疫苗在小鼠和人类中的新型杀菌抗原。
NPJ Vaccines. 2023 Apr 12;8(1):54. doi: 10.1038/s41541-023-00651-9.
2
Selection of diverse strains to assess broad coverage of the bivalent FHbp meningococcal B vaccine.选择多种菌株以评估二价因子H结合蛋白(FHbp)B群脑膜炎球菌疫苗的广泛覆盖范围。
NPJ Vaccines. 2020 Jan 29;5(1):8. doi: 10.1038/s41541-019-0154-0. eCollection 2020.
3
The role of anti-NHba antibody in bactericidal activity elicited by the meningococcal serogroup B vaccine, MenB-4C.抗NHba抗体在B群脑膜炎球菌疫苗MenB-4C引发的杀菌活性中的作用。
Vaccine. 2017 Jul 24;35(33):4236-4244. doi: 10.1016/j.vaccine.2017.06.020. Epub 2017 Jun 23.
4
Human IgG1, IgG3, and IgG3 Hinge-Truncated Mutants Show Different Protection Capabilities against Meningococci Depending on the Target Antigen and Epitope Specificity.人IgG1、IgG3和IgG3铰链区截短突变体针对脑膜炎球菌显示出不同的保护能力,这取决于靶抗原和表位特异性。
Clin Vaccine Immunol. 2016 Aug 5;23(8):698-706. doi: 10.1128/CVI.00193-16. Print 2016 Aug.
5
Construction of Opa-positive and Opa-negative strains of Neisseria meningitidis to evaluate a novel meningococcal vaccine.构建 Opa 阳性和 Opa 阴性脑膜炎奈瑟菌菌株,以评估一种新型脑膜炎球菌疫苗。
PLoS One. 2012;7(12):e51045. doi: 10.1371/journal.pone.0051045. Epub 2012 Dec 12.
6
Prospects for eradication of meningococcal disease.消除脑膜炎球菌病的前景。
Arch Dis Child. 2012 Nov;97(11):993-8. doi: 10.1136/archdischild-2012-302036. Epub 2012 Sep 15.
7
The Neisseria meningitidis macrophage infectivity potentiator protein induces cross-strain serum bactericidal activity and is a potential serogroup B vaccine candidate.脑膜炎奈瑟菌巨噬细胞感染增强蛋白诱导交叉株血清杀菌活性,是一种有潜力的 B 群疫苗候选物。
Infect Immun. 2011 Sep;79(9):3784-91. doi: 10.1128/IAI.05019-11. Epub 2011 Jun 27.
8
Potential of recombinant opa proteins as vaccine candidates against hyperinvasive meningococci.重组 Opa 蛋白作为针对高侵袭性脑膜炎奈瑟菌疫苗候选物的潜力。
Infect Immun. 2011 Jul;79(7):2810-8. doi: 10.1128/IAI.01338-10. Epub 2011 Apr 4.
9
The influence of genomics and proteomics on the development of potential vaccines against meningococcal infection.基因组学和蛋白质组学对脑膜炎奈瑟菌感染潜在疫苗开发的影响。
Genome Med. 2010 Jul 22;2(7):43. doi: 10.1186/gm164.
10
Clonal distribution of disease-associated and healthy carrier isolates of Neisseria meningitidis between 1983 and 2005 in Cuba.1983 年至 2005 年期间古巴脑膜炎奈瑟菌疾病相关和健康携带者分离株的克隆分布。
J Clin Microbiol. 2010 Mar;48(3):802-10. doi: 10.1128/JCM.01653-09. Epub 2009 Dec 30.

本文引用的文献

1
Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group.A群和C群脑膜炎奈瑟菌血清杀菌试验的标准化及多实验室比较。多实验室研究小组。
Clin Diagn Lab Immunol. 1997 Mar;4(2):156-67. doi: 10.1128/cdli.4.2.156-167.1997.
2
Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine.六价脑膜炎球菌外膜囊泡疫苗诱导产生的人抗PorA P1.7,16杀菌抗体的特异性
Infect Immun. 1996 Jul;64(7):2745-51. doi: 10.1128/iai.64.7.2745-2751.1996.
3
The 5C protein of Neisseria meningitidis is highly immunogenic in humans and induces bactericidal antibodies.脑膜炎奈瑟菌的5C蛋白在人类中具有高度免疫原性,并可诱导杀菌抗体。
J Infect Dis. 1993 May;167(5):1065-73. doi: 10.1093/infdis/167.5.1065.
4
Humoral immune response to the class 3 outer membrane protein during the course of meningococcal disease.脑膜炎球菌病病程中针对3类外膜蛋白的体液免疫反应。
Infect Immun. 1993 Nov;61(11):4734-42. doi: 10.1128/iai.61.11.4734-4742.1993.
5
Humoral immune response to class 1 outer membrane protein during the course of meningococcal disease.脑膜炎球菌病病程中对1类外膜蛋白的体液免疫反应。
Infect Immun. 1994 Apr;62(4):1437-43. doi: 10.1128/iai.62.4.1437-1443.1994.
6
Expression of the L8 lipopolysaccharide determinant increases the sensitivity of Neisseria meningitidis to serum bactericidal activity.L8脂多糖决定簇的表达增加了脑膜炎奈瑟菌对血清杀菌活性的敏感性。
Infect Immun. 1994 Dec;62(12):5290-5. doi: 10.1128/iai.62.12.5290-5295.1994.
7
Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy.巴西儿童对B群脑膜炎奈瑟菌外膜蛋白疫苗的免疫反应:与疗效比较。
Infect Immun. 1994 Oct;62(10):4419-24. doi: 10.1128/iai.62.10.4419-4424.1994.
8
Considerations on the use of Neisseria meningitidis class 5 proteins as meningococcal BC vaccine components.
Vaccine. 1995 Jan;13(1):112-8. doi: 10.1016/0264-410x(95)80021-5.
9
Development of a meningococcal vaccine.
Infect Agents Dis. 1995 Mar;4(1):13-28.
10
Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine.三剂挪威B群脑膜炎球菌疫苗接种后人体对脑膜炎球菌外膜抗原的抗体反应。
Infect Immun. 1995 Dec;63(12):4642-52. doi: 10.1128/iai.63.12.4642-4652.1995.

巴西儿童接种外膜疫苗后对B群脑膜炎球菌菌株杀菌抗体反应的特异性

Specificity of bactericidal antibody response to serogroup B meningococcal strains in Brazilian children after immunization with an outer membrane vaccine.

作者信息

Milagres L G, Gorla M C, Sacchi C T, Rodrigues M M

机构信息

Bacteriology Division, Adolfo Lutz Institute, São Paulo, SP 01246-902, Brazil.

出版信息

Infect Immun. 1998 Oct;66(10):4755-61. doi: 10.1128/IAI.66.10.4755-4761.1998.

DOI:10.1128/IAI.66.10.4755-4761.1998
PMID:9746575
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC108586/
Abstract

Pre- and postvaccination serum samples from 77 children aged 2 to 6 years, who received the Cuban BC vaccine (B:4:P1.15), were analyzed for bactericidal antibodies against a local B:4:P1.15 strain (N44/89). Sera from 16 individuals with bactericidal antibodies against the B:4:P1.15 strain were tested against 23 Brazilian isolates. These include B:4 strains of distinct serosubtypes: P1.15, P1.7,1, P1.3, P1.9, P1.nt, and a B:8,19,23:P1.16 strain. A Cuban B:4:P1.15 strain (Cu385/83) was also included in the study. The specificities of bactericidal antibodies were analyzed by using mutant strains lacking a class 1 protein (PorA protein) or a class 5 protein or both. The results indicated that PorA and class 5 proteins are the main targets recognized by the bactericidal antibodies of vaccinees. Nonetheless, a complex pattern of recognition by bactericidal antibodies was found, and vaccinees were grouped according to antibody specificity. Antibodies from some individuals recognized PorA of serosubtype P1.15. However, antibodies from these individuals could not kill all P1.15 strains tested. Antibodies from a second group recognized both PorA and class 5 proteins, and antibodies from a third group recognized an as yet unidentified target antigen. The results demonstrate the importance of determining the fine epitope specificity of bactericidal antibodies to improve the existing vaccines against B meningococci.

摘要

对77名2至6岁接种古巴B群脑膜炎球菌疫苗(B:4:P1.15)的儿童接种疫苗前后的血清样本进行分析,检测其针对本地B:4:P1.15菌株(N44/89)的杀菌抗体。对16名具有针对B:4:P1.15菌株杀菌抗体的个体的血清进行检测,以对抗23株巴西分离株。这些分离株包括不同血清亚型的B:4菌株:P1.15、P1.7,1、P1.3、P1.9、P1.nt,以及一株B:8,19,23:P1.16菌株。研究中还包括一株古巴B:4:P1.15菌株(Cu385/83)。通过使用缺乏1类蛋白(PorA蛋白)或5类蛋白或两者的突变菌株来分析杀菌抗体的特异性。结果表明,PorA和5类蛋白是疫苗接种者杀菌抗体识别的主要靶点。尽管如此,发现杀菌抗体的识别模式复杂,且根据抗体特异性对疫苗接种者进行了分组。一些个体的抗体识别血清亚型P1.15的PorA。然而,这些个体的抗体不能杀死所有测试的P1.15菌株。第二组个体的抗体识别PorA和5类蛋白,第三组个体的抗体识别一种尚未确定的靶抗原。结果表明,确定杀菌抗体的精细表位特异性对于改进现有的抗B群脑膜炎球菌疫苗非常重要。